Related Experiment Videos
Gastrointestinal disease in the immunocompromised host
1Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore, Maryland.
Radiologic Clinics of North America
|May 1, 1992
Summary
Gastrointestinal diseases are common in immunocompromised patients, including those with acquired immunodeficiency syndrome (AIDS) and after bone marrow transplants. This review covers various conditions affecting these vulnerable patient groups.
Area of Science:
- Gastroenterology
- Immunology
- Oncology
Background:
- Immunocompromised patients, including those with acquired immunodeficiency syndrome (AIDS) and recipients of bone marrow transplants (BMT), are at increased risk for gastrointestinal (GI) complications.
- These complications can stem from various causes, including opportunistic infections, malignancies, and transplant-related conditions.
Purpose of the Study:
- To review the spectrum of gastrointestinal diseases encountered in immunocompromised patients.
- To highlight specific disease entities relevant to acquired immunodeficiency syndrome (AIDS) and post-bone marrow transplant (BMT) populations.
Main Methods:
- Literature review of gastrointestinal diseases in immunocompromised patient cohorts.
- Synthesis of information on opportunistic infections, malignancies, and other GI disorders.
Main Results:
- Opportunistic infections are a significant cause of GI morbidity in AIDS and post-BMT patients.
- Malignancies, such as Kaposi's sarcoma and lymphoma, are also prevalent in these groups.
- Transplant-specific conditions like typhlitis and pseudomembranous colitis require specific diagnostic and management considerations.
Conclusions:
- Gastrointestinal manifestations in immunocompromised patients are diverse and often severe.
- Early recognition and management of GI diseases are crucial for improving outcomes in AIDS and post-BMT patients.
- Understanding the unique disease profiles in these populations is essential for effective patient care.